Intec Pharma Ltd. announced that Zeev Weiss, Chief Executive Officer and a Director of the company, is resigning from both positions effective immediately to pursue other professional opportunities. Mr. Weiss will serve as a clinical and business development consultant to Intec Pharma. The company's Board of Directors have appointed Giora Carni, a Director since 2006 and Chief Executive Officer of Intec Pharma from 2006 to 2014, as Interim Chief Executive Officer while a search for a new Chief Executive Officer has been initiated.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2.36 USD | +0.00% | +2.17% | +34.10% |
08/05 | Indaptus Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/03 | Top Premarket Gainers | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+34.10% | 2.02Cr | |
+68.62% | 6.29TCr | |
-0.90% | 4.14TCr | |
+45.66% | 4.04TCr | |
-10.72% | 2.76TCr | |
+14.81% | 2.65TCr | |
-22.24% | 1.89TCr | |
+4.18% | 1.27TCr | |
+24.13% | 1.23TCr | |
+28.99% | 1.21TCr |
- Stock Market
- Equities
- INDP Stock
- News Indaptus Therapeutics, Inc.
- Intec Pharma Ltd. Announces Management Changes